Friday, May 4, 2012

VentriPoint Launches Clinical Trial in Pulmonary Arterial Hypertension (PAH) With Top PH Centres in the United States and Canada

(SYS-CON Media) - VentriPoint Diagnostics today announced the commencement of the pivotal clinical trial to demonstrate that the VentriPoint heart analysis system is equivalent to cardiac MRI in patients with pulmonary arterial hypertension (PAH). The trial will be lead by Dr. Robyn Barst. Read article

No comments: